AXITINIB

UNII:	C9LVQ0YUXG
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₂H₁₈N₄OS
Preferred Substance Name:	AXITINIB
InChIKey:	RITAVMQDGBJQJZ-FMIVXFBMSA-N
GSRS Full Record:	C9LVQ0YUXG i

319460-85-0
AG-013736
AG-13736
Axitinib
Axitinib [INN]
Axitinib [JAN]
Axitinib [MART.]
Axitinib [MI]
Axitinib [ORANGE BOOK]
Axitinib [USAN]
Axitinib [VANDF]
Axitinib [WHO-DD]
BENZAMIDE, N-METHYL-2-((3-((1E)-2-(2-PYRIDINYL)ETHENYL)-1H-INDAZOL-6-YL)THIO)-
INLYTA
N-METHYL-2((3-((1E0-2-(PYRIDIN-2-YL)ETHENYL)-1H-INAZOL-6-YLSUFANYL)BENZAMIDE
N-METHYL-2-(3-((E)-2-PYRIDIN-2-YL-VINYL)-1H-INDAZOL-6-YLSULFANYL)-BENZAMIDE
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide
N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
NSC-757441

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

AXITINIB

Synonyms and Mappings

Resources